Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Venus Medtech (Hangzhou) Inc. has announced its 2024 first class meeting of H share holders to consider and potentially approve several resolutions, including amendments to the company’s Articles of Association and general mandates for the repurchase of H shares. The meeting is scheduled for October 10, 2024, and the resolutions details are available in the company’s recent circular. Shareholders are advised to prepare for voting and proxy arrangements in advance of the meeting.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.
